Page last updated: 2024-11-05

acetyl triethyl citrate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Acetyl triethyl citrate (ATEC) is a synthetic compound derived from citric acid. It is commonly used as a plasticizer, solvent, and fragrance ingredient. ATEC is synthesized through a reaction between citric acid and ethanol, followed by acetylation. ATEC is a colorless, viscous liquid with a mild citrus odor. It is considered a safe and effective plasticizer, imparting flexibility and durability to polymers. It is also used as a solvent in various applications, including inks, paints, and coatings. ATEC has been studied for its potential applications in various fields, including medicine, agriculture, and cosmetics. It exhibits potential antimicrobial properties and has been investigated for its role in promoting wound healing. Moreover, ATEC's biocompatibility and non-toxicity make it a promising candidate for use in drug delivery systems and biodegradable materials.'

acetyl triethyl citrate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6504
CHEMBL ID2105928
SCHEMBL ID42702
MeSH IDM0449295

Synonyms (68)

Synonym
LS-14339
citroflex a 2
triethyl acetylcitrate
triethyl citrate acetate
nsc-3887
citric acid, acetyl triethyl ester
nsc3887
77-89-4
acetyl triethyl citrate
tricarballylic acid, .beta.-acetoxytributyl ester
citroflex a-2
1,3-propanetricarboxylic acid, 2-(acetyloxy)-, triethyl ester
triethyl 2-acetoxy-1,3-propanetricarboxylate
wln: 2ov1xvo2&ov1&1vo2
atec
o-acetylcitric acid triethyl ester
1,2,3-propanetricarboxylic acid, 2-(acetyloxy)-, triethyl ester
2-(acetyloxy)-1,2,3-propanetricarboxylic acid, triethyl ester
citric acid, triethyl ester, acetate
brn 1804947
triethyl o-acetylcitrate
triethyl 2-acetoxy-1,2,3-propanetricarboxylate
nsc 3887
triethylester kyseliny acetylcitronove [czech]
tricarballylic acid, beta-acetoxytributyl ester
triethyl citrate, acetate
ai3-03574
einecs 201-066-5
triethyl 2-acetylcitrate, 99%
A0086
triethyl 2-acetyloxypropane-1,2,3-tricarboxylate
triethyl 2-acetylcitrate
FT-0659670
triethyl acetyl citrate
acetyltriethyl citrate [nf]
acetyltriethyl citrate
triethylester kyseliny acetylcitronove
1,2,3-propanetricarboxylic acid, 2-(acetyloxy)-, 1,2,3-triethyl ester
unii-5wbr36t90e
3-03-00-01105 (beilstein handbook reference)
5wbr36t90e ,
cas-77-89-4
NCGC00256002-01
tox21_301483
dtxsid5044576 ,
dtxcid3024576
CHEMBL2105928
FT-0631334
acetyltriethyl citrate [usp-rs]
acetyl triethyl citrate [inci]
acetyltriethyl citrate [mart.]
triethyl 2-acetoxypropane-1,2,3-tricarboxylate
citric acid, o-acetyltriethyl ester
SCHEMBL42702
AKOS024464792
uniplex 82
WEAPVABOECTMGR-UHFFFAOYSA-N
1,2,3-propanetricarboxylic acid, 2-acetoxy-, triethyl ester
triethyl 2-(acetyloxy)-1,2,3-propanetricarboxylate #
mfcd00049378
SR-01000944782-1
sr-01000944782
acetyltriethyl citrate, united states pharmacopeia (usp) reference standard
triethyl 2-acetylcitrate, pharmaceutical secondary standard; certified reference material
E75747
ethchlorvynolciv(0.7ml)
Q27262956
CS-W009904

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Dermal application was not toxic in rabbits."( Final report on the safety assessment of acetyl triethyl citrate, acetyl tributyl citrate, acetyl trihexyl citrate, and acetyl trioctyl citrate.
Johnson, W, 2002
)
0.58
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency51.52020.001022.650876.6163AID1224838; AID1224839
pregnane X nuclear receptorHomo sapiens (human)Potency24.33650.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency12.30280.000229.305416,493.5996AID743075
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (12.50)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.47 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index37.30 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]